Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the next five years. Key factors driving this growth include the increasing ...

The course offers key market opportunities by enabling senior managers to effectively navigate US FDA regulations, strategize applications for NDAs and generics, and understand biologics processes. It ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

Biopharma quality control is being revolutionized by advanced analytics and digital transformation through a synergy that boosts quality and scalability.

The bidding war between Pfizer ( PFE) and Novo Nordisk ( NVO) over obesity drug developer Metsera ( MTSR) finally ended over ...

Samjong KPMG announced on the 14th that it had signed a Memorandum of Understanding (MOU) with Pathway Partners at the ...

A new type of cancer cell that "warrants urgent investigation" has been discovered in childhood leukemia and could impact ...

Fall 2025, a new conference focusing on collaborations and innovative discoveries in pharmacology, InnoPharm, was held in San ...

Q3 2025 Earnings Call Transcript November 13, 2025 Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.40538, expectations were $-1.91. Operator: Good morning, ladies and ...

Explore the Wasatch U.S. Select Fund's Q3 2025 results, including underperformance vs. its benchmark and analysis of key ...

Despite challenges like high therapy costs and regulatory hurdles, continuous R&D investments and strategic collaborations are fostering progress in personalized medicine, addressing critical unmet ...

LOS ANGELES, CA – November 04, 2025 – PRESSADVANTAGE – Muse Treatment Alcohol & Drug Rehab has released a new educational ...